Silence Therapeutics Plc (SLNCF)
6.526
+0.17
(+2.70%)
USD |
OTCM |
Nov 12, 16:00
Silence Therapeutics Total Assets (Quarterly)
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 106.41M |
| March 31, 2026 | 115.12M |
| December 31, 2025 | 131.44M |
| September 30, 2025 | 146.79M |
| June 30, 2025 | 165.23M |
| March 31, 2025 | 185.30M |
| September 30, 2024 | 227.20M |
| June 30, 2024 | 238.45M |
| March 31, 2024 | 245.55M |
| Date | Value |
|---|---|
| December 31, 2023 | 119.60M |
| September 30, 2023 | 119.54M |
| June 30, 2023 | 117.87M |
| March 31, 2023 | 116.64M |
| December 31, 2022 | 129.31M |
| September 30, 2022 | 138.46M |
| June 30, 2022 | 101.29M |
| March 31, 2022 | 114.26M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 34.22M |
| Mereo BioPharma Group Plc | 29.58M |
| Compass Pathways Plc | 519.10M |
| HemoGenyx Pharmaceuticals Plc | -- |
Total Assets (Quarterly) Related Metrics
| Debt to Equity Ratio | 0.0029 |
| Current Ratio | 7.416 |
| Net Debt Paydown Yield | 0.00% |